▁One 10.375
▁of 2.494140625
▁the 1.3720703125
▁major 7.375
▁limitations 9.6015625
▁is 3.87890625
▁the 1.3115234375
▁ins 6.35546875
u 0.603515625
fficient 0.47705078125
ly 4.27734375
▁high 3.876953125
▁response 6.75390625
▁rate 3.056640625
, 2.4296875
▁ 5.60546875
5 2.4296875
7 3.359375
% 1.552734375
▁instead 8.3203125
▁of 0.2371826171875
▁ 0.3974609375
7 1.8779296875
0 1.5927734375
% 1.1640625
▁( 3.58984375
Fe 9.609375
ing 6.29296875
old 13.03125
▁et 7.57421875
▁al 1.8115234375
., 2.19921875
▁ 0.5615234375
2 0.60400390625
0 0.0357666015625
1 0.6376953125
7 2.208984375
). 0.99365234375
▁It 3.919921875
▁can 3.78515625
▁be 0.44677734375
▁fairly 7.4375
▁explained 4.94921875
▁by 2.439453125
▁the 1.271484375
▁weak 6.6875
▁focus 8.7265625
▁of 2.673828125
▁respond 6.88671875
ents 2.53125
▁who 4.7265625
▁have 2.85546875
▁overcome 8.4375
▁severe 8.828125
▁pain 5.87109375
▁sens 6.08203125
ations 4.1796875
▁and 2.46484375
▁de 6.61328125
press 2.658203125
ive 5.04296875
▁episodes 6.3359375
. 1.8427734375
▁It 3.220703125
▁is 1.212890625
▁not 3.009765625
▁clear 4.94921875
▁how 2.26171875
▁to 2.521484375
▁use 5.046875
▁these 3.3828125
▁statistics 5.15625
, 2.0234375
▁as 2.7421875
▁they 1.76171875
▁still 6.88671875
▁may 4.8046875
▁be 1.34765625
▁relevant 6.01171875
▁for 1.8408203125
▁the 1.890625
▁overall 5.42578125
▁analysis 5.05078125
. 1.4365234375
<0x0A> 1.451171875
The 1.8486328125
▁analysis 4.03125
▁of 0.7197265625
▁any 7.7578125
▁human 6.52734375
▁reaction 5.890625
▁has 4.26171875
▁a 2.396484375
▁high 4.421875
▁potential 3.298828125
▁of 1.556640625
▁subject 4.70703125
iveness 4.2265625
▁and 1.5419921875
▁bias 2.3515625
, 1.5537109375
▁especially 2.44140625
▁regarding 4.67578125
▁people 5.48046875
▁in 4.15625
▁severe 7.24609375
▁pain 1.5986328125
▁and 2.20703125
▁un 5.81640625
stable 2.7734375
▁emot 3.43359375
ional 0.55029296875
▁condition 3.431640625
. 0.359130859375
▁Perhaps 7.6796875
▁some 4.23046875
▁patients 4.30078125
▁tend 5.8125
▁to 0.0394287109375
▁ex 3.501953125
agger 0.00493621826171875
ate 0.0153961181640625
▁their 0.71435546875
▁de 7.73046875
press 1.03515625
ive 0.2320556640625
▁state 2.9453125
▁or 2.794921875
▁vice 6.73828125
▁vers 0.044525146484375
a 0.00023090839385986328
, 1.12109375
▁de 6.921875
- 5.57421875
emph 1.4658203125
as 0.00827789306640625
ize 0.451904296875
▁serious 6.96875
▁difficulties 6.93359375
. 1.4306640625
▁Because 6.07421875
▁the 2.5625
▁survey 5.95703125
▁responses 6.00390625
▁were 1.4755859375
▁thoroughly 9.0
▁anonymous 3.61328125
, 0.4453125
▁the 1.7734375
▁research 3.505859375
ers 0.55322265625
▁were 1.5693359375
▁unable 1.5537109375
▁to 0.00794219970703125
▁carefully 8.09375
▁analyze 1.7099609375
▁each 3.8046875
▁patient 2.314453125
’ 27.109375
s 4.8828125
▁reaction 4.125
▁and 2.5
▁compare 4.40234375
▁it 0.62646484375
▁to 0.8935546875
▁the 0.90234375
▁actual 3.732421875
▁states 7.5859375
▁of 0.66552734375
▁condition 7.32421875
. 0.60498046875
▁More 6.48046875
▁accurate 4.15625
▁answers 5.14453125
▁could 2.330078125
▁be 0.68701171875
▁obtained 1.0283203125
▁by 1.2041015625
▁professional 6.92578125
▁psych 2.1484375
olog 0.4541015625
ists 0.00690460205078125
▁via 8.1484375
▁personal 4.61328125
▁communication 4.4453125
▁and 2.240234375
▁behavior 7.55859375
al 0.356201171875
▁analysis 2.4453125
. 0.48046875
▁However 2.84765625
, 0.01788330078125
▁this 2.1796875
▁method 2.974609375
▁of 2.138671875
▁research 2.904296875
▁is 1.1083984375
▁way 7.5859375
▁more 1.912109375
▁resource 6.69140625
- 0.5751953125
int 0.703125
ensive 0.01092529296875
▁and 0.775390625
▁energy 8.9140625
- 0.203857421875
consum 0.31640625
ing 0.00417327880859375
. 1.17578125
<0x0A> 1.0703125
There 3.419921875
▁is 1.7255859375
▁currently 5.109375
▁a 1.7822265625
▁severe 5.52734375
▁lack 1.552734375
▁of 0.035552978515625
▁information 3.029296875
▁about 1.251953125
▁the 0.7197265625
▁effects 4.109375
▁of 0.09039306640625
▁op 3.150390625
i 4.03125
ates 0.0154266357421875
. 4.31640625
▁They 5.4921875
▁manage 9.2421875
▁pain 5.1953125
▁successfully 5.94140625
, 1.150390625
▁but 0.64697265625
▁the 2.740234375
▁past 9.6953125
▁few 2.765625
▁dec 0.73974609375
ades 0.00022470951080322266
▁indicated 7.86328125
▁the 2.24609375
▁growing 4.03125
▁concern 3.576171875
▁regarding 2.72265625
▁op 3.6875
iate 0.439453125
▁ab 1.634765625
use 0.01216888427734375
▁in 3.19140625
▁forms 9.890625
▁of 0.1248779296875
▁over 3.015625
d 0.296875
ose 0.267822265625
▁and 0.759765625
▁add 0.99658203125
iction 0.0474853515625
. 0.235107421875
▁A 4.234375
▁more 4.83984375
▁manage 9.7578125
able 0.0032825469970703125
▁and 1.912109375
▁sa 3.048828125
fer 0.00018930435180664062
▁alternative 1.8271484375
▁might 4.890625
▁be 0.128173828125
▁medical 5.66015625
▁mar 0.78369140625
iju 0.00670623779296875
ana 0.0002282857894897461
. 1.484375
▁However 2.7109375
, 0.01023101806640625
▁the 1.662109375
▁legal 3.447265625
▁status 1.513671875
▁and 2.76171875
▁novel 9.5859375
ty 0.86181640625
▁of 0.2166748046875
▁this 1.533203125
▁drug 2.0234375
▁do 5.34765625
▁not 0.09112548828125
▁allow 0.78369140625
▁finding 8.5546875
▁a 2.158203125
▁large 4.95703125
▁number 2.076171875
▁of 0.0047607421875
▁studies 2.212890625
▁on 1.7734375
▁its 1.0625
▁effect 1.6982421875
iveness 0.26416015625
. 1.3212890625
▁Specifically 8.40625
, 0.28369140625
▁it 2.548828125
▁concerns 6.140625
▁the 0.740234375
▁emot 7.80859375
ional 0.01108551025390625
▁condition 3.4765625
▁of 0.7744140625
▁patients 0.76611328125
▁experien 5.89453125
cing 0.00014972686767578125
▁chron 2.5390625
ic 0.0029201507568359375
▁pain 0.254150390625
. 0.71728515625
▁This 3.501953125
▁research 3.30078125
▁paper 5.65234375
▁a 3.015625
ims 0.0009121894836425781
▁to 0.1568603515625
▁analyze 2.484375
▁levels 9.734375
▁of 0.05609130859375
▁de 1.0126953125
pression 0.1990966796875
▁and 0.7841796875
▁anx 0.896484375
iety 0.0014286041259765625
▁among 1.833984375
▁people 3.087890625
▁receiving 4.3828125
▁ther 5.19921875
apy 0.109619140625
▁by 5.16015625
▁comparing 6.9921875
▁the 1.5966796875
▁effects 3.599609375
▁of 0.1400146484375
▁ph 5.66796875
arma 1.0341796875
ce 0.0027923583984375
ut 0.0004322528839111328
ical 0.00841522216796875
▁op 1.1171875
io 2.12109375
ids 0.301513671875
▁and 1.1796875
▁MM 8.15625
. 6.625
<0x0A> 1.462890625
The 1.521484375
▁question 5.453125
na 2.6796875
ires 0.0008897781372070312
▁used 2.5234375
▁different 10.2265625
▁variable 8.2578125
▁measures 3.7734375
▁to 1.875
▁collect 2.9921875
▁information 2.083984375
. 1.958984375
▁For 3.32421875
▁example 0.8212890625
, 0.0248260498046875
▁it 4.84765625
▁included 4.31640625
▁compreh 8.609375
ensive 0.0273590087890625
▁so 6.03515625
cio 0.041046142578125
- 0.272705078125
dem 0.06787109375
ographic 0.06365966796875
▁data 1.2421875
: 5.29296875
▁gender 1.8828125
, 0.12396240234375
▁age 0.2216796875
, 0.08245849609375
▁country 4.19921875
, 1.333984375
▁type 3.77734375
▁of 0.057159423828125
▁residence 5.19921875
▁( 2.66796875
urban 2.12890625
/ 2.408203125
r 0.05670166015625
ural 0.0011091232299804688
), 0.4716796875
▁years 5.4453125
▁of 0.1649169921875
▁education 0.74169921875
, 0.29296875
▁and 2.16015625
▁employ 3.51171875
ment 0.00543212890625
▁status 0.383056640625
. 0.291748046875
▁Pat 4.33203125
ients 0.14794921875
▁were 1.22265625
▁also 1.2412109375
▁asked 0.354736328125
▁about 1.13671875
▁their 0.7744140625
▁medical 3.078125
▁history 0.449462890625
▁over 8.53125
▁the 0.177490234375
▁years 3.865234375
▁and 2.126953125
▁the 2.115234375
▁current 3.185546875
▁presence 5.80078125
▁of 0.06280517578125
▁any 2.263671875
▁severe 4.90625
▁dise 2.013671875
ases 0.00020194053649902344
▁such 4.0703125
▁as 0.0083465576171875
▁heart 2.48828125
▁failure 2.361328125
, 0.150390625
▁di 1.8037109375
ab 0.002315521240234375
etes 0.00582122802734375
, 0.2415771484375
▁ar 3.654296875
th 0.09844970703125
rit 0.041534423828125
is 0.01528167724609375
, 0.1278076171875
▁and 2.056640625
▁so 2.2421875
▁on 0.169677734375
. 0.04071044921875
▁The 2.068359375
▁third 6.3125
▁measure 4.4375
▁of 2.19921875
▁the 1.4638671875
▁question 1.076171875
naire 0.23193359375
▁was 0.88623046875
▁indicated 9.6328125
▁by 0.859375
▁information 6.90625
▁on 1.59765625
▁any 5.0
▁twelve 13.796875
- 0.9765625
month 0.54296875
▁and 5.8515625
▁lifetime 3.4140625
▁drug 4.9296875
▁and 3.6484375
▁alco 0.076171875
hol 8.034706115722656e-05
▁consumption 2.751953125
. 0.59619140625
▁In 3.4765625
▁addition 0.84228515625
, 0.10272216796875
▁the 1.251953125
▁record 8.1875
▁included 2.15625
▁a 2.513671875
▁pain 6.6171875
▁measurement 4.4609375
▁scale 1.1357421875
▁from 3.498046875
▁ 0.50439453125
0 0.478759765625
▁to 0.485595703125
▁ 0.007427215576171875
1 0.1046142578125
0 0.06414794921875
▁to 4.7890625
▁evaluate 2.259765625
▁dis 6.3203125
com 0.25390625
fort 0.0012254714965820312
▁feelings 7.09765625
▁during 2.9921875
▁the 0.65087890625
▁last 1.583984375
▁month 1.818359375
. 0.338623046875
<0x0A> 1.2568359375
Chr 7.48828125
onic 0.0212249755859375
▁pain 0.2115478515625
▁is 0.9189453125
▁still 5.51171875
▁considered 2.326171875
▁to 2.265625
▁be 0.029449462890625
▁an 2.412109375
▁extreme 5.71484375
▁issue 4.8671875
▁among 3.541015625
▁at 9.4140625
▁least 0.307373046875
▁ 0.7890625
8 2.6875
% 3.55859375
▁of 0.07513427734375
▁the 0.461669921875
▁residents 7.95703125
▁of 0.80615234375
▁progress 12.9375
ive 0.424560546875
▁countries 0.91845703125
. 0.83984375
▁The 2.087890625
▁introduction 7.375
▁of 0.059478759765625
▁the 2.705078125
▁study 5.97265625
▁describes 8.546875
▁the 0.99365234375
▁apparent 8.375
▁link 5.45703125
▁between 0.153564453125
▁pain 2.76953125
▁and 0.454345703125
▁dem 9.2890625
oral 2.67578125
ization 0.21533203125
. 1.076171875
▁Chron 4.76953125
ic 0.006893157958984375
▁pain 0.137939453125
▁is 1.4130859375
▁always 5.9140625
▁accompanied 1.2236328125
▁by 0.1326904296875
▁negative 3.734375
▁emot 0.8154296875
ional 1.064453125
▁experiences 3.923828125
▁and 1.98828125
▁blocks 10.1171875
▁a 3.5546875
▁person 1.041015625
’ 26.0
s 0.036712646484375
▁ability 1.33203125
▁to 0.03173828125
▁receive 6.11328125
▁joy 4.69921875
▁and 1.3447265625
▁satisfaction 2.873046875
▁from 1.212890625
▁life 1.0205078125
. 0.254638671875
▁The 1.8935546875
▁research 3.052734375
▁investig 4.73046875
ates 0.55322265625
▁the 0.55419921875
▁development 7.2265625
▁of 0.153564453125
▁de 1.455078125
pression 0.28662109375
▁and 0.53564453125
▁anx 0.1666259765625
iety 0.0017328262329101562
▁among 1.626953125
▁patients 0.966796875
▁receiving 1.1962890625
▁ph 3.025390625
arma 0.123291015625
ce 0.0015106201171875
ut 0.00011205673217773438
ical 0.0027103424072265625
▁op 0.6044921875
io 0.1392822265625
ids 0.12176513671875
▁and 0.8662109375
▁medical 1.349609375
▁mar 0.08538818359375
iju 0.0050048828125
ana 3.24249267578125e-05
▁( 3.26953125
MM 0.11212158203125
) 1.27734375
▁as 2.767578125
▁severe 10.078125
▁pain 0.705078125
kill 5.5703125
ers 0.0009436607360839844
. 0.33837890625
▁It 2.669921875
▁comp 4.50390625
ares 0.0282440185546875
▁the 0.5341796875
▁effic 5.4609375
acy 0.0027637481689453125
▁of 0.2376708984375
▁pres 5.43359375
cri 1.81640625
ptions 0.458740234375
▁and 1.9228515625
▁exam 5.7890625
ines 0.012969970703125
▁the 0.55322265625
▁possibility 3.9765625
▁of 0.1339111328125
▁post 7.30078125
- 0.429931640625
tre 1.3486328125
at 0.0007495880126953125
ment 0.00460052490234375
▁de 3.5546875
pression 0.1536865234375
. 2.1484375
<0x0A> 0.6611328125
The 1.0283203125
▁study 2.404296875
▁conducted 5.35546875
▁a 1.8232421875
▁correlation 5.75
▁type 7.3359375
▁of 0.378662109375
▁research 1.7998046875
▁with 2.572265625
▁variable 8.4765625
▁measures 1.1572265625
. 1.5927734375
▁It 2.373046875
▁evaluated 5.375
▁the 0.6240234375
▁inter 5.875
dep 3.685546875
end 0.0011186599731445312
ence 0.01258087158203125
▁of 0.61572265625
▁various 4.515625
▁factors 1.67578125
▁that 2.7890625
▁affected 4.2421875
▁the 0.5732421875
▁physical 6.37890625
▁and 0.6982421875
▁emot 0.865234375
ional 0.0006575584411621094
▁condition 0.978515625
▁of 0.124755859375
▁patients 0.57373046875
▁experien 4.9296875
cing 5.3763389587402344e-05
▁chron 0.4619140625
ic 0.0004012584686279297
▁pain 0.046295166015625
. 0.1778564453125
▁For 2.916015625
▁example 0.329345703125
, 0.0157318115234375
▁the 1.2412109375
▁survey 4.01953125
▁showed 4.23828125
▁that 0.60107421875
▁the 1.662109375
▁ratio 7.05859375
▁of 0.1328125
▁female 3.890625
▁patients 0.93896484375
▁was 1.8671875
▁remark 9.0390625
ably 0.0006508827209472656
▁higher 0.4755859375
▁in 3.140625
▁the 2.146484375
▁op 5.08984375
i 3.375
ates 0.04925537109375
▁group 0.313232421875
▁compared 2.728515625
▁to 0.13134765625
▁the 0.572265625
▁MM 0.2607421875
▁group 0.489990234375
. 0.1947021484375
▁In 2.908203125
▁turn 5.50390625
, 0.0045166015625
▁people 5.1796875
▁on 5.55859375
▁op 1.4404296875
i 0.3232421875
ates 0.001953125
▁were 1.158203125
▁more 1.072265625
▁likely 0.38623046875
▁to 0.0673828125
▁report 2.69140625
▁major 6.265625
▁de 0.3955078125
press 1.0380859375
ive 0.0033321380615234375
▁dis 0.61376953125
orders 1.126953125
. 1.7744140625
<0x0A> 2.888671875
Part 6.46484375
icip 0.325927734375
ants 0.11212158203125
▁were 1.271484375
▁rec 3.20703125
ru 0.0011777877807617188
ited 5.447864532470703e-05
▁for 3.3515625
▁six 8.296875
▁months 0.71533203125
▁at 3.65625
▁two 2.44921875
▁major 4.12109375
▁pain 2.4765625
▁relief 5.640625
▁cent 1.474609375
ers 0.018341064453125
▁in 0.55322265625
▁Israel 4.40234375
. 0.385498046875
▁All 3.044921875
▁patients 0.91162109375
▁experienced 4.01953125
▁chron 1.439453125
ic 0.0006575584411621094
▁pain 0.2078857421875
▁for 1.9033203125
▁at 0.619140625
▁least 0.0008859634399414062
▁ 1.669921875
3 1.7138671875
▁months 0.275390625
. 0.85498046875
▁The 1.3876953125
▁study 2.33984375
▁included 2.380859375
▁ 1.076171875
8 2.693359375
9 2.91796875
0 4.55078125
▁participants 2.068359375
, 1.458984375
▁of 1.830078125
▁which 0.467041015625
▁ 0.166259765625
4 1.3720703125
7 2.52734375
4 2.76171875
▁( 2.25390625
5 0.07916259765625
9 11.4453125
%) 0.66796875
▁were 0.59912109375
▁treated 3.564453125
▁sole 7.18359375
ly 0.00014543533325195312
▁with 0.3125
▁op 0.466796875
io 1.5498046875
ids 0.1737060546875
, 1.3408203125
▁ 0.8388671875
3 0.96728515625
2 2.064453125
9 2.65625
▁( 0.06884765625
4 1.0947265625
1 1.2255859375
%) 0.095458984375
▁were 1.439453125
▁treated 0.59619140625
▁with 0.1956787109375
▁MM 0.90185546875
, 0.2406005859375
▁and 0.1357421875
▁ 0.2064208984375
7 3.142578125
7 2.42578125
▁( 0.1904296875
8 3.59375
. 1.275390625
6 3.27734375
%) 0.04412841796875
▁acquired 9.7734375
▁both 0.958984375
▁( 6.55078125
Fe 8.53125
ing 0.33447265625
old 0.006534576416015625
▁et 0.3525390625
▁al 0.0100250244140625
., 0.0478515625
▁ 0.00672149658203125
2 0.0189666748046875
0 8.344650268554688e-05
1 0.06103515625
7 0.464599609375
). 0.0670166015625
▁The 1.4619140625
▁remaining 6.3984375
▁ten 7.375
▁participants 1.4599609375
▁who 5.43359375
▁did 1.3984375
▁not 0.007602691650390625
▁receive 2.20703125
▁ph 3.271484375
arma 0.047119140625
ce 0.0018253326416015625
ut 2.2411346435546875e-05
ical 0.003448486328125
▁op 0.51318359375
io 0.125
ids 0.03668212890625
▁and 1.9609375
▁medical 3.46484375
▁mar 0.045654296875
iju 0.003997802734375
ana 4.374980926513672e-05
▁were 1.1162109375
▁with 6.35546875
dra 0.1597900390625
wn 0.00014638900756835938
▁from 0.223388671875
▁the 0.09588623046875
▁analysis 4.234375
▁in 4.90234375
▁the 1.4013671875
▁research 4.3203125
. 0.55224609375
▁Therefore 5.03125
, 0.01151275634765625
▁it 3.158203125
▁is 1.2646484375
▁not 2.806640625
▁possible 0.79345703125
▁to 0.0211334228515625
▁compreh 7.01171875
ens 0.060089111328125
ively 0.008026123046875
▁compare 1.802734375
▁patients 4.625
▁taking 4.9609375
▁medic 4.29296875
ations 0.76953125
▁with 1.10546875
▁those 1.087890625
▁who 1.0712890625
▁do 2.232421875
▁not 0.010894775390625
. 0.8505859375
<0x0A> 0.61083984375
The 0.8935546875
▁study 2.083984375
▁was 2.421875
▁conducted 1.080078125
▁in 1.3251953125
▁the 2.166015625
▁form 2.705078125
▁of 0.00466156005859375
▁collection 10.109375
▁and 1.9140625
▁analysis 0.89892578125
▁of 0.0322265625
▁statistical 4.125
▁data 0.143310546875
. 0.6025390625
▁Part 4.2890625
icip 0.028564453125
ants 0.034393310546875
▁were 0.7490234375
▁rec 2.609375
ru 0.001407623291015625
ited 1.4424324035644531e-05
▁for 0.83935546875
▁six 0.5185546875
▁months 0.0146026611328125
▁at 0.25439453125
▁two 0.05035400390625
▁major 0.222412109375
▁pain 0.01201629638671875
▁relief 0.0094146728515625
▁cent 0.013946533203125
ers 0.0019445419311523438
▁in 0.0362548828125
▁Israel 0.0170745849609375
. 0.0980224609375
▁The 1.388671875
▁research 1.9326171875
ers 2.119140625
▁used 2.740234375
▁The 8.21875
▁De 4.4296875
pression 0.0301361083984375
▁Module 9.6796875
▁of 1.11328125
▁the 0.275634765625
▁Pat 2.1796875
ient 0.01412200927734375
▁Health 0.2232666015625
▁Question 0.0111846923828125
naire 0.019866943359375
▁and 3.779296875
▁the 0.619140625
▁General 2.140625
ized 0.90087890625
▁An 0.0186614990234375
x 9.191036224365234e-05
iety 0.0015659332275390625
▁Dis 0.41162109375
order 0.04827880859375
▁Sc 1.2548828125
ale 0.07366943359375
▁to 1.59765625
▁interview 7.546875
▁participants 1.6142578125
, 4.08203125
▁evaluate 5.1640625
▁their 0.83837890625
▁answers 6.84765625
, 0.5849609375
▁and 0.0921630859375
▁conduct 4.27734375
▁the 2.017578125
▁study 2.931640625
. 0.313720703125
▁To 5.30859375
▁specifically 8.9296875
▁evaluate 2.337890625
▁and 4.66796875
▁compare 0.90087890625
▁the 0.53759765625
▁prob 10.5703125
abilities 0.1220703125
▁of 0.1402587890625
▁de 1.1552734375
pression 0.1654052734375
▁or 3.884765625
▁anx 0.046661376953125
iety 0.0003924369812011719
▁among 1.8955078125
▁the 2.337890625
▁diverse 8.7265625
▁groups 1.216796875
, 1.353515625
▁the 0.84814453125
▁study 2.73828125
▁used 1.3076171875
▁multiple 4.37890625
▁log 2.7578125
istic 0.02569580078125
▁regression 0.1173095703125
▁analysis 0.63623046875
▁and 2.501953125
▁chose 9.1796875
▁medical 7.7734375
▁mar 0.403564453125
iju 0.0013170242309570312
ana 4.291534423828125e-05
▁as 0.7080078125
▁the 0.90283203125
▁control 2.4296875
▁group 0.55126953125
. 0.359619140625
<0x0A> 0.77490234375
This 3.9921875
▁type 4.09765625
▁of 0.004856109619140625
▁study 2.189453125
▁is 1.3212890625
▁the 3.21484375
▁most 0.962890625
▁reve 8.6796875
aling 0.00116729736328125
▁and 0.80029296875
▁inclus 6.21484375
ive 0.003353118896484375
, 2.326171875
▁as 1.75390625
▁it 0.306640625
▁contains 5.03515625
▁direct 6.02734375
▁responses 4.0078125
▁from 0.96337890625
▁a 4.24609375
▁large 1.0
▁number 0.501953125
▁of 0.003940582275390625
▁participants 1.423828125
. 0.53515625
▁All 4.48828125
▁tools 8.8984375
▁in 4.63671875
▁the 0.5791015625
▁form 3.669921875
▁of 0.0450439453125
▁question 1.234375
na 0.029876708984375
ires 7.200241088867188e-05
▁and 2.66796875
▁scales 3.37890625
▁have 4.16796875
▁already 4.60546875
▁been 0.258544921875
▁used 2.25390625
▁and 2.052734375
▁proved 4.671875
▁their 1.59375
▁effic 3.625
acy 0.00030994415283203125
▁for 3.2734375
▁collect 4.6484375
ing 0.01050567626953125
▁analyt 8.296875
ical 0.2587890625
▁data 0.316650390625
. 0.44384765625
▁It 3.240234375
▁helps 4.96484375
▁to 0.8798828125
▁system 6.81640625
at 1.5966796875
ize 0.010101318359375
▁and 1.5712890625
▁class 4.375
ify 0.0032444000244140625
▁distinct 8.8828125
▁kinds 6.5234375
▁of 0.018402099609375
▁information 3.53125
▁for 4.11328125
▁subsequent 4.27734375
▁un 7.91796875
comp 5.2109375
licated 0.0543212890625
▁services 12.1328125
. 0.84765625
▁Thus 4.46484375
, 0.019256591796875
▁research 4.31640625
ers 0.29931640625
▁can 1.255859375
▁compare 3.88671875
▁the 1.134765625
▁effects 2.716796875
▁of 0.0859375
▁medic 3.873046875
ations 0.390380859375
▁on 1.5234375
▁patients 2.09375
▁of 4.21875
▁diverse 4.2265625
▁age 2.158203125
▁groups 1.099609375
, 0.7646484375
▁background 4.62890625
s 0.281005859375
, 0.048187255859375
▁physical 5.6328125
▁conditions 1.2294921875
, 0.0843505859375
▁emot 4.51171875
ional 0.048492431640625
▁states 1.26171875
, 0.11712646484375
▁and 0.43603515625
▁so 1.7021484375
▁on 0.0521240234375
. 0.07940673828125
<0x0A> 0.6201171875
Am 6.8203125
ong 0.0301513671875
▁all 2.423828125
▁participants 2.763671875
▁in 3.0625
▁the 0.171875
▁study 0.336181640625
, 0.07806396484375
▁ 0.66455078125
4 1.19921875
2 3.78125
. 1.5673828125
2 2.3671875
% 0.1724853515625
▁suffered 4.85546875
▁from 0.08685302734375
▁de 1.1162109375
pression 0.2445068359375
, 1.0751953125
▁and 2.060546875
▁ 0.169189453125
3 1.70703125
7 2.2109375
% 2.693359375
▁experienced 2.220703125
▁excess 8.15625
ive 0.1368408203125
▁anx 0.1434326171875
iety 0.0018568038940429688
. 0.31591796875
▁The 1.3623046875
▁pl 10.8671875
ur 0.900390625
ality 0.00017213821411132812
▁of 0.1923828125
▁de 3.853515625
press 1.3017578125
ive 0.032012939453125
▁dis 1.888671875
orders 0.056732177734375
▁among 3.525390625
▁patients 1.12890625
▁in 3.744140625
▁the 0.387451171875
▁op 1.6533203125
i 1.212890625
ates 0.003887176513671875
, 7.15234375
▁medical 3.55078125
▁mar 0.0191650390625
iju 0.006221771240234375
ana 5.2809715270996094e-05
, 0.14013671875
▁and 0.0721435546875
▁mixed 6.046875
▁OP 8.9453125
MM 5.52734375
▁groups 0.4716796875
▁number 8.015625
ed 0.0090789794921875
▁ 0.10943603515625
5 2.1796875
7 2.185546875
. 0.3837890625
1 2.37890625
%, 0.304931640625
▁ 0.0087738037109375
2 3.08984375
2 2.498046875
. 0.09771728515625
3 2.240234375
%, 0.0960693359375
▁and 0.0341796875
▁ 0.0032367706298828125
5 3.142578125
1 2.556640625
. 0.1607666015625
4 2.158203125
%, 0.375732421875
▁respectively 0.01065826416015625
. 0.3349609375
▁The 1.3759765625
▁pl 4.33203125
ur 0.021820068359375
ality 2.8014183044433594e-05
▁of 0.040374755859375
▁anx 0.90478515625
iety 0.01198577880859375
▁contained 11.1484375
▁ 0.51416015625
4 1.7119140625
8 2.4453125
. 0.06842041015625
4 2.322265625
% 0.57470703125
▁among 1.4365234375
▁OP 6.328125
▁patients 8.3828125
, 0.2919921875
▁ 0.12127685546875
2 1.4833984375
1 2.390625
. 0.1318359375
5 2.4140625
% 0.01213836669921875
▁among 0.408935546875
▁MM 0.658203125
▁patients 0.237548828125
, 0.0128326416015625
▁and 0.01505279541015625
▁ 0.03466796875
3 1.2705078125
8 2.66796875
. 0.1539306640625
7 2.302734375
% 0.0145111083984375
▁among 0.2340087890625
▁OP 4.0703125
MM 0.274658203125
▁participants 3.4453125
. 0.259521484375
▁Pat 5.9296875
ients 0.0213165283203125
▁who 2.236328125
▁took 3.01171875
▁strong 7.6640625
▁op 1.37890625
i 1.513671875
ates 0.003093719482421875
▁were 1.9814453125
▁t 9.2265625
ended 1.205078125
▁to 0.0165557861328125
▁place 10.515625
▁their 3.59375
▁pain 3.396484375
▁on 3.27734375
▁a 1.0556640625
▁scale 2.77734375
▁of 0.462646484375
▁ 0.349853515625
9 2.9609375
▁to 1.326171875
▁ 0.01335906982421875
1 0.035614013671875
0 0.06549072265625
▁( 2.349609375
Fe 1.0029296875
ing 0.00868988037109375
old 0.00147247314453125
▁et 0.044219970703125
▁al 0.0009813308715820312
., 0.00969696044921875
▁ 0.001155853271484375
2 0.00030684471130371094
0 3.898143768310547e-05
1 0.0006146430969238281
7 0.00591278076171875
). 0.0244293212890625
▁They 4.67578125
▁were 1.27734375
▁also 1.45703125
▁an 8.8125
gu 4.4765625
ished 0.035369873046875
▁em 8.203125
otion 0.01129913330078125
ally 0.0031986236572265625
▁and 1.111328125
▁react 6.890625
ed 0.051666259765625
▁rad 9.4765625
ically 0.00261688232421875
▁neg 5.0859375
atively 0.0008087158203125
▁to 0.3759765625
▁almost 5.39453125
▁all 1.0927734375
▁survey 7.5546875
▁questions 0.64990234375
. 0.28076171875
▁Pat 4.265625
ients 0.00701141357421875
▁who 1.146484375
▁took 1.5791015625
▁only 5.21484375
▁MM 1.1484375
▁or 3.4140625
▁mixed 3.19921875
▁medic 2.740234375
ations 0.29296875
▁course 12.578125
▁had 2.40234375
▁a 1.3369140625
▁significantly 2.544921875
▁more 3.962890625
▁stable 3.572265625
▁emot 1.3681640625
ional 0.01214599609375
▁state 0.8173828125
▁and 1.2607421875
▁cop 5.5859375
ed 0.8173828125
▁with 0.7294921875
▁pain 1.45703125
▁more 1.69921875
▁manage 7.0
able 2.224609375
. 0.55419921875
